A First-in-Human Study of PRL3-ZUMAB

NCT03191682 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: PRL3-ZUMAB

Sponsor

National University Hospital, Singapore

Collaborators

[object Object]